快速诊断市场规模、份额、成长分析，按产品、按来源、按技术、按分销管道、按最终用途、按地区 - 行业预测，2025 年至 2032 年

2023 年全球快速诊断市场规模价值 364 亿美元，预计将从 2024 年的 441.2 亿美元成长到 2032 年的 2054.1 亿美元，预测期内（2025-2032 年）的复合年增长率为 21.2%。

全球感染疾病和慢性病的迅速增加以及对精准诊断的需求不断增长，预计将推动快速诊断市场大幅成长。对创新诊断技术研究的持续投入为产业供应商创造了新的机会。照护现场和家庭检测解决方案的日益普及进一步推动了这一势头。此外，政府积极采取措施提高早期诊断意识并改善快速诊断技术，预计将在 2031 年之前增加快速诊断公司的收益。然而，先进诊断产品的高成本、熟练专业人员的短缺、严格的法规环境和供应链问题等挑战可能会阻碍整个研究期间及以后的广泛采用。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

快速诊断市场规模（按产品划分）

• 市场概况
• 传染病检查
  • 呼吸道传染病检查产品
  • 流感
  • 肝炎
  • HIV
  • 其他传染病检查
• 血糖监测
• 心臟代谢检测
• 血液凝固检验产品
• 妊娠和生育能力测试
• 肿瘤/癌症标记检测产品
• 尿液检查产品
• 胆固醇检测产品
• 血液检测产品
• 药物滥用 (DOA) 检测产品
• 大便潜血试验产品
• 其他产品

快速诊断市场规模（按购买目的地划分）

• 市场概况
• 在商店
• 处方笺测试

按技术分類的快速诊断市场规模

• 市场概况
• 流通式
• 固相
• 横向流动
• 聚集测定
• 其他技术

按分销管道分類的快速诊断市场规模

• 市场概况
• 医院药房
• 店铺
• 电子商务
• 其他分销管道

快速诊断市场规模（按最终用途划分）

• 市场概况
• 诊断中心
• 居家护理
• 医院药房
• 其他最终用户

快速诊断市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Abbott Laboratories（USA）
• Roche Diagnostics（Switzerland）
• Danaher（USA）
• Siemens Healthineers（Germany）
• Johnson & Johnson（USA）
• Thermo Fisher Scientific（USA）
• BD（Becton, Dickinson and Company）（USA）
• QuidelOrtho（USA）
• Bio-Rad Laboratories（USA）
• Hologic（USA）
• Cepheid（USA）
• Ortho Clinical Diagnostics（USA）
• Siemens Healthineers（Germany）
• Sysmex（Japan）
• Fujifilm Holdings（Japan）
• DiaSorin（Italy）
• BioMerieux（France）
• Instrumentation Laboratory（USA）

结论和建议

Global Rapid Diagnostics Market size was valued at USD 36.4 billion in 2023 and is poised to grow from USD 44.12 billion in 2024 to USD 205.41 billion by 2032, growing at a CAGR of 21.2% during the forecast period (2025-2032).

The global surge in infectious and chronic diseases, coupled with an increasing demand for precision diagnostics, is poised to drive significant growth in the rapid diagnostics market. Continued investment in researching innovative diagnostic technologies will create new opportunities for industry providers. The rising popularity of point-of-care and home-based testing solutions further supports this momentum. Additionally, proactive government initiatives aimed at enhancing awareness of early diagnosis and improving rapid diagnostic technologies are anticipated to bolster revenue for rapid diagnostics companies through 2031. However, challenges such as the high costs associated with advanced diagnostic products, a shortage of skilled professionals, stringent regulatory environments, and supply chain issues may hinder widespread adoption throughout the study period and beyond.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Rapid Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Rapid Diagnostics Market Segments Analysis

Global Rapid Diagnostics Market is segmented by Product, Purchase, Technology, Distribution Channel, End Use and region. Based on Product, the market is segmented into Infectious Disease Testing, Glucose Monitoring, Cardiometabolic Testing, Coagulation Testing Products, Pregnancy And Fertility Testing, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Fecal Occult Testing Products and Other Products. Based on Purchase, the market is segmented into OTC and Prescription-Based Tests. Based on Technology, the market is segmented into Flow-Through, Solid Phase, Lateral Flow, Agglutination Assays and Other Technologies. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Brick & Mortar, E-Commerce and Other Distribution Channels. Based on End Use, the market is segmented into Diagnostic Centers, Homecare Settings, Hospital Pharmacies and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Rapid Diagnostics Market

The Global Rapid Diagnostics market is experiencing significant growth driven by the rising prevalence of infectious diseases worldwide. As these diseases become more widespread, there is an increasing demand for effective diagnostic solutions. Rapid testing enables timely detection of infections, allowing for prompt interventions that can prevent the escalation of outbreaks into potential pandemics. This heightened awareness of infectious diseases and the importance of accurate diagnostics is further propelling the demand for rapid diagnostic tools. Consequently, the need for advanced diagnostic procedures is pivotal in addressing health crises and ensuring public safety on a global scale.

Restraints in the Global Rapid Diagnostics Market

The Global Rapid Diagnostics market faces significant constraints due to stringent regulations imposed by authorities and governments, necessitating comprehensive documentation and testing. These rigorous compliance requirements create challenges for companies in the sector, often leading to delays in obtaining necessary approvals for their products. This intricate approval process can hinder innovation and slow the overall growth trajectory of the rapid diagnostics market, potentially affecting its future outlook and limiting timely access to critical diagnostic tools. Consequently, the complex regulatory environment poses a substantial barrier to the advancement and widespread adoption of rapid diagnostics technologies.

Market Trends of the Global Rapid Diagnostics Market

The Global Rapid Diagnostics market is witnessing a significant trend towards the integration of artificial intelligence (AI) technologies, enhancing accuracy and efficiency in diagnostic processes. Companies are increasingly harnessing AI for predictive analytics, enabling early disease detection and improved patient outcomes. This shift is driven by the rapid digitization of healthcare, which facilitates real-time data analysis and personalized medicine approaches. As AI continues to evolve, it will create new opportunities in the rapid diagnostics sector, ultimately optimizing healthcare workflows and fostering innovation. This trend is expected to shape the landscape of diagnostics, paving the way for smarter, faster, and more reliable healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Rapid Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Infectious Disease Testing
  • Respiratory Infection Testing Products
  • Influenza
  • Hepatitis
  • HIV
  • Other Infectious Disease Tests
• Glucose Monitoring
• Cardiometabolic Testing
• Coagulation Testing Products
• Pregnancy And Fertility Testing
• Tumor/Cancer Marker Testing Products
• Urinalysis Testing Products
• Cholesterol Testing Products
• Hematology Testing Products
• Drug-Of-Abuse (DOA) Testing Products
• Fecal Occult Testing Products
• Other Products

Global Rapid Diagnostics Market Size by Purchase & CAGR (2025-2032)

• Market Overview
• OTC
• Prescription-Based Tests

Global Rapid Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Flow-Through
• Solid Phase
• Lateral Flow
• Agglutination Assays
• Other Technologies

Global Rapid Diagnostics Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Brick & Mortar
• E-Commerce
• Other Distribution Channels

Global Rapid Diagnostics Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Diagnostic Centers
• Homecare Settings
• Hospital Pharmacies
• Other End Users

Global Rapid Diagnostics Market Size & CAGR (2025-2032)

• North America (Product, Purchase, Technology, Distribution Channel, End Use)
  • US
  • Canada
• Europe (Product, Purchase, Technology, Distribution Channel, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Purchase, Technology, Distribution Channel, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Purchase, Technology, Distribution Channel, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Purchase, Technology, Distribution Channel, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Instrumentation Laboratory (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations